What we do
Autologous Cell Therapy
Allogenic Cell Therapy
Enzyme Therapy
Medical Device
The healiva® Approach
Our pipeline products address the entire spectrum of the wound-care process for chronic wounds, from key first steps to the completion of closure.
Autologous Cell Graft
Chronic Wounds
Our personalised solution that promotes the complete closure of chronic wounds, including vascular leg ulcers.
Allogenic Cell Spray
Chronic Wounds
Our scalable treatment for chronic leg ulcers that are not responding to standard of care, using automated manufacturing.
Enzymatic Debrider Spray
Chronic & Acute Wounds
Our easy-to-use, and painless enzymatic debridement spray clears dead tissue to support physiological healing processes.
Autologous Cell Grafting
Medical device
Our first-in-class autologous cell grafting medical device is rapid, cost-effective, intuitive, and safe to use, enabling personalised treatment of wounds at the point-of-care.
Chronic Wounds
#1 Wound bed preparation
healiva® 003: Enzymatic debrider spray cleans wounds, creates barrier to infection, and kickstart physiological repair mechanisms
#2 Intervention: Autologous Cell Graft and allogenic cell spray
healiva® 001/002/004 Cell therapy interventions for severe, hard to heal wounds
#3 Completion of wound closure
Timeline
2020
2022
2023
2024
2025
2026
